苑東生物(688513.SH):擬出資2.45億元參設蘇州守正壹期創業投資合夥企業
格隆匯2月15日丨苑東生物(688513.SH)公佈,為更好地實施成都苑東生物製藥股份有限公司戰略發展規劃,公司擬與守正創贏(蘇州)創業投資有限公司(“蘇州創投”)、蘇州天使創業投資引導基金管理有限公司、蘇州高新創業投資集團有限公司、蘇州醫療器械產業發展有限公司、楊昊共同發起設立蘇州守正壹期創業投資合夥企業(有限合夥)(具體以工商登記為準),該基金專注於大健康產業,聚焦於生物醫藥領域,重點投向創新藥、生物藥,其他可投資於醫療器械、精準醫療、醫藥/醫療技術服務或技術平台等大健康領域。
該基金規模為人民幣5億元,全體合夥人分兩次認繳出資,其中公司作為有限合夥人(LP)之一以自有資金認繳出資2.45億元。
公司藉助專業投資機構的行業經驗、資源優勢及管理平台,獲取相應的行業資源與潛在直投標的儲備;另一方面,結合基金管理人及普通合夥人的管理經驗和風險控制體系,幫助公司把握早期項目投資機會,降低投資風險,獲得投資收益,提升公司的盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.